Theriva Biologics, Inc. (SFY.F)
| Previous close | 0.3700 |
| Open | 0.3560 |
| Bid | 0.3270 x N/A |
| Ask | 0.3675 x N/A |
| Day's range | 0.3560 - 0.3560 |
| 52-week range | 0.3230 - 1.2800 |
| Volume | |
| Avg. volume | 18 |
| Market cap | 6.151M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript
Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript March 25, 2024 Theriva Biologics, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41. Theriva Biologics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to […]
- Thomson Reuters StreetEvents
Q4 2023 Theriva Biologics Inc Earnings Call
Q4 2023 Theriva Biologics Inc Earnings Call
- Insider Monkey
Theriva Biologics, Inc. (NYSE:TOVX) Q3 2023 Earnings Call Transcript
Theriva Biologics, Inc. (NYSE:TOVX) Q3 2023 Earnings Call Transcript November 17, 2023 Operator: Greetings, and welcome to the Theriva Biologics, Inc. 2023 Third Quarter Operational Highlights and Financial Results. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Steve Shallcross. Thank you. You may begin. […]
